sbc medical group holdings inc - SBC

SBC

Close Chg Chg %
4.39 0.00 0.00%

Closed Market

4.39

0.00 (0.00%)

Volume: 39.58K

Last Updated:

Dec 30, 2025, 4:00 PM EDT

Company Overview: sbc medical group holdings inc - SBC

SBC Key Data

Open

$4.43

Day Range

4.22 - 4.43

52 Week Range

2.62 - 7.00

Market Cap

$450.31M

Shares Outstanding

102.58M

Public Float

3.29M

Beta

1.21

Rev. Per Employee

N/A

P/E Ratio

10.56

EPS

$0.42

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

85.96K

 

SBC Performance

1 Week
 
-1.13%
 
1 Month
 
22.97%
 
3 Months
 
3.78%
 
1 Year
 
-21.04%
 
5 Years
 
N/A
 

SBC Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 2
Full Ratings ➔

About sbc medical group holdings inc - SBC

SBC Medical Group Holdings, Inc. engages in management services and products to cosmetic treatment centers. The company was founded on January 20, 2023 and is headquartered in Irvine, CA.

SBC At a Glance

SBC Medical Group Holdings, Inc.
200 Spectrum Center Drive
Irvine, California 92618
Phone 1-949-593-0250 Revenue 205.42M
Industry Miscellaneous Commercial Services Net Income 46.61M
Sector Commercial Services Employees 863
Fiscal Year-end 12 / 2025
View SEC Filings

SBC Valuation

P/E Current 10.559
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 11.519
Price to Sales Ratio 2.614
Price to Book Ratio 2.928
Price to Cash Flow Ratio 9.70
Enterprise Value to EBITDA 4.755
Enterprise Value to Sales 2.064
Total Debt to Enterprise Value 0.029

SBC Efficiency

Revenue/Employee 238,024.962
Income Per Employee 54,014.224
Receivables Turnover 4.262
Total Asset Turnover 1.43

SBC Liquidity

Current Ratio 3.014
Quick Ratio 2.831
Cash Ratio 2.043

SBC Profitability

Gross Margin 74.869
Operating Margin 41.556
Pretax Margin 35.76
Net Margin 22.693
Return on Assets 32.447
Return on Equity 44.454
Return on Total Capital 22.484
Return on Invested Capital 42.87

SBC Capital Structure

Total Debt to Total Equity 6.26
Total Debt to Total Capital 5.891
Total Debt to Total Assets 4.59
Long-Term Debt to Equity 3.972
Long-Term Debt to Total Capital 3.738
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Sbc Medical Group Holdings Inc - SBC

Collapse All in section
All values USD millions. 2022 2023 2024 5-year trend
Sales/Revenue
- - - 205.42M
-
Sales Growth
- - - -
-
Cost of Goods Sold (COGS) incl D&A
- - - 51.62M
-
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
- - - 3.80M
-
Depreciation
- - - 2.73M
-
Amortization of Intangibles
- - - 1.07M
-
COGS Growth
- - - -
-
Gross Income
- - - 153.79M
-
Gross Income Growth
- - - -
-
Gross Profit Margin
- - - +74.87%
-
2022 2023 2024 5-year trend
SG&A Expense
- 543.70K 1.64M 68.43M
Research & Development
- - - -
-
Other SG&A
- 543.70K 1.64M 68.43M
SGA Growth
- - +200.80% +4,084.13%
-
Other Operating Expense
- - - 137.38K
-
Unusual Expense
- - - 18.21M
-
EBIT after Unusual Expense
- (543.70K) (1.77M) 67.16M
Non Operating Income/Expense
- 1.35M 2.64M 6.33M
Non-Operating Interest Income
- 1.35M 2.64M 19.94K
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
- - - 28.30K
-
Interest Expense Growth
- - - -
-
Gross Interest Expense
- - - 28.30K
-
Interest Capitalized
- - - -
-
Pretax Income
- 801.32K 868.58K 73.46M
Pretax Income Growth
- - +8.39% +8,357.04%
-
Pretax Margin
- - - +35.76%
-
Income Tax
- 248.51K 528.81K 26.77M
Income Tax - Current - Domestic
- 328.74K 782.44K 41.18M
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
- (80.23K) (253.63K) (14.42M)
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
- 552.81K 339.77K 46.69M
Minority Interest Expense
- - - 75.62K
-
Net Income
- 552.81K 339.77K 46.61M
Net Income Growth
- - -38.54% +13,619.48%
-
Net Margin Growth
- - - +22.69%
-
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
- 552.81K 339.77K 46.61M
Preferred Dividends
- - - -
-
Net Income Available to Common
- 552.81K 339.77K 46.61M
EPS (Basic)
- 0.0367 0.0384 0.4827
EPS (Basic) Growth
- - +4.63% +1,157.03%
-
Basic Shares Outstanding
- 15.07M 8.85M 96.56M
EPS (Diluted)
- 0.0367 0.0381 0.4827
EPS (Diluted) Growth
- - +3.81% +1,166.93%
-
Diluted Shares Outstanding
- 15.07M 8.91M 96.56M
EBITDA
- (543.70K) (1.77M) 89.16M
EBITDA Growth
- - -226.07% +5,129.36%
-
EBITDA Margin
- - - +43.41%
-

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 8.167
Number of Ratings 2 Current Quarters Estimate 0.103
FY Report Date 03 / 2026 Current Year's Estimate 0.48
Last Quarter’s Earnings 0.115 Median PE on CY Estimate N/A
Year Ago Earnings 0.463 Next Fiscal Year Estimate 0.56
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 3 3 3 2
Mean Estimate 0.10 0.12 0.48 0.56
High Estimates 0.11 0.13 0.50 0.59
Low Estimate 0.10 0.11 0.45 0.53
Coefficient of Variance 5.59 9.36 5.51 7.58

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 1 1 0
OVERWEIGHT 1 1 1
HOLD 0 0 0
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Overweight Overweight Overweight

Sbc Medical Group Holdings Inc in the News